tiprankstipranks
Advertisement
Advertisement

AU:AGN Stock Latest News

Argenica Options Lapse Trims Potential Diluted Capital
Company AnnouncementsArgenica Options Lapse Trims Potential Diluted Capital
2d ago
AGN
Argenica Highlights Neuroprotection Strategy in New Investor Briefing
PremiumCompany Announcements
Argenica Highlights Neuroprotection Strategy in New Investor Briefing
19d ago
AGN
WHO Confirms International Generic Name for Argenica’s Lead Stroke Drug
PremiumCompany Announcements
WHO Confirms International Generic Name for Argenica’s Lead Stroke Drug
2M ago
AGN
Argenica Options Lapse Clarifies Capital Structure
PremiumCompany Announcements
Argenica Options Lapse Clarifies Capital Structure
2M ago
AGN
Argenica Advances ARG-007 Stroke Program and Strengthens Funding for Phase 2b Trial
PremiumCompany Announcements
Argenica Advances ARG-007 Stroke Program and Strengthens Funding for Phase 2b Trial
4M ago
AGN
Argenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
PremiumCompany AnnouncementsArgenica boosts cash reserves with $3.97m R&D rebate to advance stroke drug
5M ago
AGN
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
Premium
Company Announcements
Argenica Widens Half-Year Loss as ARG-007 Stroke Trial Spending Climbs
6M ago
AGN
Argenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
Premium
Company Announcements
Argenica Wins EMA Paediatric Waiver, Streamlining EU Pathway for Stroke Drug ARG-007
6M ago
AGN
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
PremiumCompany Announcements
Argenica’s AI Analysis Confirms ARG-007 Efficacy in Severe Stroke, Paving Way for Phase 2b Trial
7M ago
AGN
Argenica Therapeutics Announces Departure of Director Di Angus
PremiumCompany Announcements
Argenica Therapeutics Announces Departure of Director Di Angus
8M ago
AGN
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
PremiumCompany Announcements
Argenica Chair Steps Down as Biotech Prepares for Next Growth Phase
8M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
PremiumCompany Announcements
Argenica’s ARG-007 Shows Promising Results in Severe Stroke Patients
8M ago
AGN
Argenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
PremiumCompany AnnouncementsArgenica’s ARG-007 Shows Promising Results in Preclinical Stroke Study
9M ago
AGN
Argenica Therapeutics AGM Resolutions Passed Successfully
Premium
Company Announcements
Argenica Therapeutics AGM Resolutions Passed Successfully
9M ago
AGN
Argenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
Premium
Company Announcements
Argenica Therapeutics Advances ARG-007 Amidst Clinical and Market Challenges
9M ago
AGN
Argenica Therapeutics Announces Retirement of Key Board Member
PremiumCompany Announcements
Argenica Therapeutics Announces Retirement of Key Board Member
9M ago
AGN
Argenica Therapeutics Advances Stroke Treatment with Promising Trial Results
PremiumCompany Announcements
Argenica Therapeutics Advances Stroke Treatment with Promising Trial Results
10M ago
AGN
Argenica Therapeutics Issues New Equity Securities as Part of Employee Incentive Scheme
PremiumCompany Announcements
Argenica Therapeutics Issues New Equity Securities as Part of Employee Incentive Scheme
10M ago
AGN
Argenica Therapeutics Reports Positive Phase 2 Trial Results for Stroke Treatment
PremiumCompany Announcements
Argenica Therapeutics Reports Positive Phase 2 Trial Results for Stroke Treatment
10M ago
AGN
Argenica Therapeutics Announces Details for Upcoming Annual General Meeting
PremiumCompany AnnouncementsArgenica Therapeutics Announces Details for Upcoming Annual General Meeting
10M ago
AGN
Argenica Therapeutics Unveils Strategic Presentation at ASX Conference
Premium
Company Announcements
Argenica Therapeutics Unveils Strategic Presentation at ASX Conference
11M ago
AGN
Argenica Therapeutics Sets Date for Annual General Meeting
Premium
Company Announcements
Argenica Therapeutics Sets Date for Annual General Meeting
11M ago
AGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >